ELITE PHARMACEUTICALS INC Contracts & Agreements

114 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Elite Pharmaceuticals, Inc. Restated 2014 Equity Incentive Plan
Bonus & Incentive Agreements
ELITE PHARMACEUTICALS INC
2024
Asset Purchase Agreement, dated June 17, 2024, by and between the Company and Nostrum Laboratories Inc
Purchase Agreements
ELITE PHARMACEUTICALS INC
2024
Employment Agreement, dated September 5, 2023, between Elite Pharmaceuticals, Inc. and Carter Ward
Employment Agreements
ELITE PHARMACEUTICALS INC
2023
Employment Agreement, dated April 27, 2023, between Elite Pharmaceuticals, Inc. and Mark Pellegrino
Employment Agreements
ELITE PHARMACEUTICALS INC
2023
Employment Agreement, dated September 5, 2022, between Elite Pharmaceuticals, Inc. and Kirko Kirkov
Employment Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2022
Agreement for Sale and Purchase of Real Estate, dated April 8, 2022, by and between Clyde Wesp and Margaret Wesp as trustees of the Wesp Family Joint Living Trust UTD November 19,...
Purchase Agreements
ELITE PHARMACEUTICALS INC
2022
Loan and Security Agreement, dated April 1, 2022, by and among East West Bank, Elite Pharmaceuticals, Inc. and Elite Laboratories, Inc
Loan Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2022
License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Lannett Company, Inc, dated October 18, 2021
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2022
License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Lannett Company, Inc, dated October 18, 2021
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2022
License and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Dexcel Ltd. (Or Akiva, Israel), dated December 6, 2021
License Agreements
ELITE PHARMACEUTICALS INC
2022
February 18, 2022 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2022
License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals and Lannett, Inc., dated July 20, 2021
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2022
Employment Agreement, dated May 5, 2022, between Elite Pharmaceuticals, Inc. and Robert Chen
Employment Agreements
ELITE PHARMACEUTICALS INC
2022
Master Development and License Agreement for Products Between Elite Pharmaceuticals, Inc. and Mikah Pharma LLC, effective as of June 10, 2021.(Portions of this Agreement have been...
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2021
Employment Agreement with Douglas Plassche
Employment Agreements
ELITE PHARMACEUTICALS INC
2021
June 21, 2019 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
2021
July 29, 2019 Amendment To The License, Supply And Distribution Agreement Between Elite Pharmaceuticals, Inc./Elite Laboratories, Inc. And Lannett Company, Inc. (Portions of this...
License Agreements
ELITE PHARMACEUTICALS INC
2021
Employment Agreement, dated April 26, 2021, between Elite Pharmaceuticals, Inc. and Marc Bregman
Employment Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2021
Series J Preferred Stock and Series J Common Stock Purchase Warrant anti-dilution waiver
Warrant Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2020
August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC
Purchase Agreements
ELITE PHARMACEUTICALS INC
2020
Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
Purchase Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
IL
2020
Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
ELITE PHARMACEUTICALS INC
2020
Description of Common Stock
Stock Agreements
ELITE PHARMACEUTICALS INC
2020
Employment Agreement with Douglas Plassche
Employment Agreements
ELITE PHARMACEUTICALS INC
2020
June 21, 2019 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2020
July 29, 2019 Amendment To The License, Supply And Distribution Agreement Between Elite Pharmaceuticals, Inc./Elite Laboratories, Inc. And Lannett Company, Inc. (Portions of this...
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2020
August 1, 2018 Amendment to the Glenmark Pharmaceuticals Inc. USA License, Supply and Distribution Agreement (portions of this Agreement have been redacted in compliance with...
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2020
License, Supply And Distribution Agreement effective March 6, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA...
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Asset Purchase Agreement dated November 13, 2019 by and between the Company and Nostrum Laboratories Inc
Purchase Agreements
ELITE PHARMACEUTICALS INC
2020
January 2, 2020 Amendment to the Glenmark Pharmaceuticals Inc. USA License, Supply and Distribution Agreement (portions of this Agreement have been redacted in compliance with...
License Agreements
ELITE PHARMACEUTICALS INC
2020
Asset Purchase Agreement executed January 16, 2020 by and between the Company and Nostrum Laboratories Inc
Purchase Agreements
ELITE PHARMACEUTICALS INC
2020
License, Supply And Distribution Agreement effective April 9, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA...
License Agreements
ELITE PHARMACEUTICALS INC
2019
License, Supply And Distribution Agreement effective March 6, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA...
License Agreements
ELITE PHARMACEUTICALS INC
2019
Development Agreement effective December 3, 2018 by and between Mikah Pharma LLC and Elite Laboratories, Inc. (portions of this Agreement have been redacted in compliance with...
Development Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2019
August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC
Purchase Agreements
ELITE PHARMACEUTICALS INC
2018
May 29, 2018 License, Manufacturing and Supply Agreement with Glenmark Pharmaceuticals Inc. USA. Confidential portions of this exhibit have been redacted and filed separately with...
Exchange Agreements
ELITE PHARMACEUTICALS INC
2018
MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN
License Agreements
ELITE PHARMACEUTICALS INC
2017
SECOND AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN PHARMA, LLC
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2017
FIRST AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN PHARMA, LLC
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2017
ASSET PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2017
ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. SECURED NOTE DUE 2020
Note Agreements
ELITE PHARMACEUTICALS INC
2017
ANDA SECURITY AGREEMENT
Security Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2017
ASSIGNMENT AGREEMENT
Assignment Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2017
ASSIGNMENT AGREEMENT
Assignment Agreements
ELITE PHARMACEUTICALS INC
2017
SUPPLY AND DISTRIBUTION AGREEMENT
Supply Agreements
ELITE PHARMACEUTICALS INC
2017
MANUFACTURING AND SUPPLY AGREEMENT
Supply Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2017
PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
IL
2017
COMMON STOCK PURCHASE WARRANT ElitePharmaceuticals, inc.
Warrant Agreements
ELITE PHARMACEUTICALS INC
2017
EXCHANGE AGREEMENT
Exchange Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2017
MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN
License Agreements
ELITE PHARMACEUTICALS INC
2016
Signature page to follow 165 Ludlow Avenue • Northvale, NJ 07647• Ph: (201 ###-###-#### • Fax: (201 ###-###-#### www.elitepharma.com
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2016
165 Ludlow Avenue • Northvale, NJ 07647• Ph: (201 ###-###-#### • Fax: (201 ###-###-#### www.elitepharma.com
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2016
AMENDMENT 1 TO EMPLOYMENT AGREEMENT
Employment Agreements
ELITE PHARMACEUTICALS INC
2016
LICENSE AGREEMENT
License Agreements
ELITE PHARMACEUTICALS INC
2015
165 Ludlow Avenue• Northvale, NJ 07647 • Ph: (201 ###-###-#### • Fax: (201 ###-###-#### www.elitepharma.com {***} Confidentialportions of this exhibit have been redacted and...
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2015
First Amendment to Loan Agreement
Loan Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2015
TERMINATION OF DEVELOPMENT AND LICENSEAGREEMENT FOR MIKAH-001 BETWEEN ELITE PHARMACEUTICALS , INC. AND MIKAH PHARMA LLC AND TRANSFER OF PAYMENT
Termination Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2015
EMPLOYMENT AGREEMENT
Employment Agreements
ELITE PHARMACEUTICALS INC
2014
PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
2014
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
IL
2014
CERTIFICATE OF DESIGNATION of SERIES I CONVERTIBLE PREFERRED STOCK of ELITE PHARMACEUTICALS, INC., (Pursuant to Section 78.1955 of the Nevada Revised Statutes)
Stock Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2014
ELITEPHARMACEUTICALS, INC. incorporatedunder the laws of the state of nevada SERIES I CONVERTIBLE PREFERRED STOCK
Stock Agreements
ELITE PHARMACEUTICALS INC
2014
AMENDMENT TO THE AUGUST 1, 2013 SECURED CONVERTIBLENOTE TO MIKAH PHARMA LLC DUE AUGUST 1, 2016IN THE PRINCIPAL AMOUNT OF $10,000,000
ELITE PHARMACEUTICALS INC
2014
AMENDMENT TO THE NOVEMBER 21, 2013 SECURED CONVERTIBLENOTE TO JERRY TREPPEL DUE NOVEMBER 21, 2016 IN THE PRINCIPALAMOUNT OF $600,000
ELITE PHARMACEUTICALS INC
2014
ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. CONVERTIBLE NOTE DUE 2016
Note Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2013
LOAN AGREEMENT
Loan Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2013
MANUFACTURING AND LICENSE AGREEMENT Between Elite Pharmaceuticals, Inc. and Epic Pharma LLC
License Agreements
ELITE PHARMACEUTICALS INC
2013
CONFIDENTIAL MASTER SERVICES AGREEMENT
Services Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2013
Exhibit 10. 12 SCHEDULE 1 ABBREVIATED NEW DRUG APPLICATIONS
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2013
Exhibit 10.15
ELITE PHARMACEUTICALS INC
2013
Amendment No. 2 to Treppel Loan Agreement
Loan Agreements
ELITE PHARMACEUTICALS INC
2013
ASSET PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
DE
2013
ELITE PHARMACEUTICALS, INC. AND ELITELABORATORIES, INC. SECURED CONVERTIBLE NOTE DUE 2016
Note Agreements
ELITE PHARMACEUTICALS INC
2013
ANDA SECURITY AGREEMENT
Security Agreements
ELITE PHARMACEUTICALS INC
2013
EMPLOYMENT AGREEMENT
Employment Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2013
ELITE PHARMACEUTICALS, INC. CERTIFICATE OF DESIGNATIONS OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES G PREFERRED STOCK Pursuant to NRS 78.1955
Stock Agreements
ELITE PHARMACEUTICALS INC
2013
ELITE PHARMACEUTICALS, INC. incorporatedunder the laws of the state of nevada SERIES G CONVERTIBLE PREFERRED STOCK
Stock Agreements
ELITE PHARMACEUTICALS INC
2013
PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
2013
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
ELITE PHARMACEUTICALS INC
2013
Amendment No. 1 to Treppel Loan Agreement
Loan Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2012
Exhibit 10.6
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2012
Exhibit 10. 77 MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCT BETWEEN ELITE PHARMACEUTICALS, INC. AND {***}
License Agreements
ELITE PHARMACEUTICALS INC
2012
LOAN AGREEMENT
Loan Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2012
AMENDMENT AGREEMENT
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NY
2012
AGREEMENT AND PLAN OF MERGER By and Between ELITE PHARMACEUTICALS, INC. (a Nevada corporation) and ELITE PHARMACEUTICALS INC. (a Delaware corporation) AGREEMENT AND PLAN OF MERGER
Merger Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NV
2012
Elite Pharmaceuticals, Inc. Warrant To Purchase Common Stock
Warrant Agreements
ELITE PHARMACEUTICALS INC
2012
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ELITE PHARMACEUTICALS INC
2012
AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR {***} BETWEEN ELITE PHARMACEUTICALS, INC. AND MIKAH PHARMA, LLC
License Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2011
MANUFACTURING AND SUPPLY AGREEMENT
Supply Agreements
ELITE PHARMACEUTICALS INC
2011
MANUFACTURING AND SUPPLY AGREEMENT
Supply Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2011
Execution Copy Settlement Agreement
Settlement Agreements
ELITE PHARMACEUTICALS INC
2011
DEVELOPMENT AND SUPPLYAGREEMENT FOR GENERIC{***} BETWEEN ELITEPHARMACEUTICALS AND HI-TECH PHARMACAL CO.INC.
Development Agreements
ELITE PHARMACEUTICALS INC
2011
ASSET PURCHASEAGREEMENT
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2010
ASSET PURCHASEAGREEMENT
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2010
MASTER DEVELOPMENT ANDLICENSE AGREEMENT FOR {***} BETWEEN ELITE PHARMACEUTICALS, INC. AND MIKAHPHARMA, LLC
Development Agreements
ELITE PHARMACEUTICALS INC
2010
PURCHASEAGREEMENT between ELITEPHARMACEUTICALS, INC. and EPICPHARMA, LLC Dated asof September 10, 2010
ELITE PHARMACEUTICALS INC
2010
LICENSEAGREEMENT
ELITE PHARMACEUTICALS INC
Pharmaceuticals
IL
2010
MANUFACTURINGAND SUPPLY AGREEMENT
Supply Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
IL
2010
Proprietary Rights Agreement (see attached)
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2009
210,000,000 SHARES OF COMMON STOCK PAR VALUE $0.01 PER SHARE 4,483,442 SHARES OF PREFERRED STOCK PAR VALUE $0.01 PER SHARE *S*P*E*C*I*M*E*N
Stock Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2009
WARRANT TO PURCHASE 40,000,000 SHARES OF COMMON STOCK OF ELITE PHARMACEUTICALS, INC. Exercise Price: $0.0625 per share, subject to adjustment as provided below (the "Exercise...
Warrant Agreements
ELITE PHARMACEUTICALS INC
2009
- 2 -
ELITE PHARMACEUTICALS INC
2009
Execution Version
ELITE PHARMACEUTICALS INC
2009
STRATEGIC ALLIANCE AGREEMENT
ELITE PHARMACEUTICALS INC
2009
INTRODUCTION
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2008
[SIGNATURE PAGE FOLLOWS] 2
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NY
2008
BACKGROUND
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NY
2008
BACKGROUND
ELITE PHARMACEUTICALS INC
2008
INTRODUCTION
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2008
BACKGROUND
ELITE PHARMACEUTICALS INC
2008
INTRODUCTION
ELITE PHARMACEUTICALS INC
2008
R E C I T A L S:
ELITE PHARMACEUTICALS INC
2008
COMMON STOCK PURCHASE WARRANT To Purchase 75,000 Shares of Common Stock of ELITE PHARMACEUTICALS, INC.
Warrant Agreements
ELITE PHARMACEUTICALS INC
2007